Geographic Variation in Human Papillomavirus Vaccination Initiation and Completion Among Young Adults in the US

被引:13
作者
Boakye, Eric Adjei [1 ,2 ]
Babatunde, Oluwole A. [3 ]
Wang, Maggie [4 ]
Osazuwa-Peters, Nosayaba [5 ]
Jenkins, Wiley [1 ,2 ]
Lee, Minjee [1 ,2 ]
Kim, Minjin [6 ]
机构
[1] Southern Illinois Univ, Dept Populat Sci & Policy, Sch Med, 201 East Madison St,POB 19664, Springfield, IL 62794 USA
[2] Southern Illinois Univ, Simmons Canc Inst, Sch Med, Springfield, IL 62794 USA
[3] Med Univ South Carolina, Dept Psychiat, Charleston, SC 29425 USA
[4] St Louis Univ, Sch Med, St Louis, MO USA
[5] Duke Univ, Dept Head & Neck Surg & Commun Sci, Sch Med, Durham, NC USA
[6] Univ Massachusetts, Dept Populat & Quantitat Hlth Sci, Med Sch, Boston, MA 02125 USA
关键词
D O I
10.1016/j.amepre.2020.09.005
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: This study explores how human papillomavirus vaccination initiation and completion among men and women aged 18-34 years varies by geographic region. Methods: Data from the 2015-2017 Behavioral Risk Factor Surveillance System were analyzed. Geographic regions for the selected states were defined as South, Northeast, and Midwest/West. Human papillomavirus vaccination initiation was defined as receipt of >= 1 dose, and completion was defined as receipt of >= 3 doses. Weighted, multivariable logistic regression models estimated the association between geographic region and vaccine uptake, adjusting for sociodemographic, health, and healthcare factors. Analyses were performed in November 2019. Results: A total of 18,078 adults were included in the study, 80% of whom resided in the South. The overall vaccination initiation rate was 23.4%, and the completion rate was 11.0%. Initiation was higher among those who resided in the Northeast (38.6%), followed by Midwest/West (23.8%), and lowest for those in the South (21.8%) (p<0.0001). Completion rates followed the same trend as initiation. In the adjusted models, compared with the adults residing in the Northeast, those living in the South were less likely to initiate (AOR=0.47, 95% CI=0.40, 0.55) and complete (AOR=0.56, 95% CI=0.46, 0.68) human papillomavirus vaccination. Conclusions: Human papillomavirus vaccine uptake was low for all regions, but vaccine uptake was significantly lower in the South region. This demonstrates the need to identify barriers specifically associated with the Southern population, which may include differing levels of education and insurance. Such work is especially pertinent because many Southern states face increased risk of human papillomavirus-associated cancers such as cervix and oral cavity and pharynx cancers. (C) 2020 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:387 / 396
页数:10
相关论文
共 43 条
[1]  
[Anonymous], HIV surveillance report.
[2]  
[Anonymous], MERCK HELPS
[3]   Risk Factors for Oral HPV Infection among a High Prevalence Population of HIV-Positive and At-Risk HIV-Negative Adults [J].
Beachler, Daniel C. ;
Weber, Kathleen M. ;
Margolick, Joseph B. ;
Strickler, Howard D. ;
Cranston, Ross D. ;
Burk, Robert D. ;
Wiley, Dorothy J. ;
Minkoff, Howard ;
Reddy, Susheel ;
Stammer, Emily E. ;
Gillison, Maura L. ;
D'Souza, Gypsyamber .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (01) :122-133
[4]  
Benard VB, 2014, MMWR-MORBID MORTAL W, V63, P1004
[5]   Differences in human papillomavirus (HPV) vaccine uptake by nativity status among men aged 18-34 years [J].
Boakye, Eric Adjei ;
Zeng, Wenhui ;
Governor, Samuel ;
Nagendra, Shreya ;
Tobo, Betelihem B. ;
Simpson, Matthew C. ;
Osazuwa-Peters, Nosayaba .
PREVENTIVE MEDICINE REPORTS, 2019, 16
[6]   Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma [J].
Boakye, Eric Adjei ;
Buchanan, Paula ;
Hinyard, Leslie ;
Osazuwa-Peters, Nosayaba ;
Schootman, Mario ;
Piccirillo, Jay F. .
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2018, 144 (08) :727-737
[7]   Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States [J].
Boakye, Eric Adjei ;
Lew, Daphne ;
Muthukrishnan, Meera ;
Tobo, Betelihem B. ;
Rohde, Rebecca L. ;
Varvares, Mark A. ;
Osazuwa-Peters, Nosayaba .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (08) :2016-2024
[8]   Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States [J].
Chaturvedi, Anil K. ;
Engels, Eric A. ;
Pfeiffer, Ruth M. ;
Hernandez, Brenda Y. ;
Xiao, Weihong ;
Kim, Esther ;
Jiang, Bo ;
Goodman, Marc T. ;
Sibug-Saber, Maria ;
Cozen, Wendy ;
Liu, Lihua ;
Lynch, Charles F. ;
Wentzensen, Nicolas ;
Jordan, Richard C. ;
Altekruse, Sean ;
Anderson, William F. ;
Rosenberg, Philip S. ;
Gillison, Maura L. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (32) :4294-4301
[9]   Human Papillomavirus in Head and Neck Cancer: Its Role in Pathogenesis and Clinical Implications [J].
Chung, Christine H. ;
Gillison, Maura L. .
CLINICAL CANCER RESEARCH, 2009, 15 (22) :6758-6762
[10]   Regional variation in human papillomavirus vaccination uptake and completion among adolescents 13-17 in the state of Texas [J].
Conrey, Reghan ;
Valencia, Victoria ;
Cioletti, Anne ;
Williams-Brown, M. Yvette .
VACCINE, 2020, 38 (25) :4119-4124